About
Founded in 2023 by Jordi Parramon, PhD and William Marks, MD and with the addition of Jon Lundt, PhD, the firm brings a deep commitment to helping those with neurodegenerative, neuropsychiatric, and neurodevelopmental disorders, such as Parkinson’s disease, bipolar disorder, and autism spectrum disorder. Adjacent to these sentinel disorders are many other brain disorders that are also within scope for Nexus NeuroTech Ventures.
Key facts
At-a-glance profile data
- Website
- nexusneurotech.com
- Type
- Venture Capital
- Headquarters
- United States
- Portfolio companies
- 2
- Stages
- Series BSeries F
- Cheque size
- $22M to $150M
- Sector focus
- HealthcareAutismDiagnosticsUltrasoundTherapy
Recent investments
Add first review
Frequently asked
What companies has Nexus NeuroTech Ventures invested in?
Nexus NeuroTech Ventures has invested in Insightec, EarliTec Diagnostics.
